Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy

Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis

Published Date: November 2009

Published By: Aruvian's R'search

Page Count: 40

Order Code: R3456-373

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Search Inside
this Report

Similar
Products

Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition.Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions. The process of “drug discovery/invention” is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market.

Aruvian's R'search analyzes the Pharmaceutical Industry in United States in the Michael Porter’s Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macroenvironment. They consist of those forces close to a company that affect its ability to serve its customers and make a profit. A change in any of the forces normally requires a company to re-assess the marketplace.

Similar Products

• Snapshots US Pharmaceuticals 2009

Published Nov 2009 by Snapdata International Group

• Pharmaceutical Industry in Mexico

Published Nov 2009 by Aruvian's R'search

• Pharmaceuticals Industry Report

Published Nov 2009 by Plimsoll Publishing Ltd.

• Antipsychotics Market Forecast

Published Oct 2009 by Datamonitor

• Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes

Published Oct 2009 by Datamonitor

• Prescription Drug Wholesaling in the US - Industry Risk Rating Report